Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
- Harvard Medical School, MD
- Harvard University, PhD
- Princeton University, BA
- Published on 9/6/2023
Sethi S, Beck LH, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int. 2023 Sep 06. PMID: 37795587.
- Published on 8/8/2023
Avasare R, Andeen N, Beck L. Novel Antigens and Clinical Updates in Membranous Nephropathy. Annu Rev Med. 2023 Aug 08. PMID: 37552894.
- Published on 6/21/2023
Beck LH, Ayoub I, Caster D, Choi MJ, Cobb J, Geetha D, Rheault MN, Wadhwani S, Yau T, Whittier WL. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Am J Kidney Dis. 2023 Aug; 82(2):121-175. PMID: 37341661.
- Published on 12/29/2022
Al-Rabadi LF, Beck LH. Neuronal Proteins as Antigenic Targets in Membranous Nephropathy. Nephron. 2023; 147(8):451-457. PMID: 36580905.
- Published on 11/29/2022
Burbelo PD, Olson SW, Keller JM, Joshi M, Schwartz DM, Chuang YJ, Lambeau G, Beck LH, Waldman M. Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy. Kidney360. 2023 Feb 01; 4(2):217-225. PMID: 36821613.
- Published on 9/29/2022
Sealfon R, Mariani L, Kretzler M, Beck LH. Authors' Reply: In Silico-Based Approach to the Discovery of New Antigens in Membranous Nephropathy. J Am Soc Nephrol. 2022 Dec; 33(12):2322-2323. PMID: 36175144.
- Published on 7/7/2022
Manral P, Caza TN, Storey AJ, Beck LH, Borza DB. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy. Front Immunol. 2022; 13:952235. PMID: 35874690.
- Published on 4/27/2022
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH. Molecular Characterization of Membranous Nephropathy. J Am Soc Nephrol. 2022 Jun; 33(6):1208-1221. PMID: 35477557.
- Published on 1/1/2022
Kamel MH, Jaberi A, Gordon CE, Beck LH, Francis J. The Complement System in the Modern Era of Kidney Transplantation: Mechanisms of Injury and Targeted Therapies. Semin Nephrol. 2022 Jan; 42(1):14-28. PMID: 35618392.
- Published on 11/26/2021
Caza TN, Al-Rabadi LF, Beck LH. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol. 2021; 12:800242. PMID: 34899763.
View 82 more publications: View full profile at BUMC